Paul Sondel, MD, PhD, was recently awarded a grant of $50,000 from the UW Institute for Clinical and Translational Research (UW-ICTR) type 1 pilot grant program for his project, “In Depth Delineation of FcyRIIc and FcyRIIIa Genotypes and Potential Clinical Implications.” This project aims to develop a new method to determine differences in patient genotypes and correlate genetic differences with the patient’s innate immune system to mediate clinical benefit.